As of December 15, 2025, Chill N Out Cryotherapy Inc's estimated intrinsic value ranges from $0.03 to $0.03 per share, depending on the valuation methodology applied.
| Valuation Method | Fair Value (USD) | Implied Upside/Downside |
|---|---|---|
| Dividend Discount Model (Stable) | $0.03 | +26919.3% |
Is Chill N Out Cryotherapy Inc (CHNO) undervalued or overvalued?
With the current market price at $0.00, the stock appears to be significantly undervalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Chill N Out Cryotherapy Inc's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
| WACC Component | Low | High |
|---|---|---|
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.02 | 1.27 |
| Cost of equity | 8.6% | 12.0% |
| Cost of debt | 5.0% | 5.0% |
| Tax rate | 26.2% | 27.0% |
| Debt/Equity ratio | 1 | 1 |
| After-tax WACC | 6.1% | 7.8% |
The DDM values a company based on its expected future dividend payments. We used two approaches:
| Metric | Value |
|---|---|
| Market Capitalization | $0M |
| Enterprise Value | $0M |
| Trailing P/E | 0.03 |
| Forward P/E | 0.03 |
| Trailing EV/EBITDA | 0.00 |
| Current Dividend Yield | 0.00% |
| Dividend Growth Rate (5Y) | 0.00% |
| Debt-to-Equity Ratio | 5.31 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
| Valuation Method | Weight | Weighted Value |
|---|---|---|
| Dividend Discount Model (Stable) | 100% | $0.00 |
| Weighted Average | 100% | $0.03 |
Based on our comprehensive valuation analysis, Chill N Out Cryotherapy Inc's intrinsic value is $0.03, which is approximately 26919.3% above the current market price of $0.00.
Key investment considerations:
Given these factors, we believe Chill N Out Cryotherapy Inc is currently significantly undervalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.